Table 4.
Distribution of Antibiotics Prescribed for Patients Admitted to Selected Wards of AKU-CSH, Aksum, Northern Ethiopia, 2020
| Antibiotics | Involved Wards, n (%) | Total, n (%) | Proportion (95% CI) | ||
|---|---|---|---|---|---|
| Surgical (n=384) | Medical (n=313) | Gyn/Obs (n=125) | |||
| Ampicillin injection | 5 (0.5) | 0 (0.0) | 87 (46.3) | 92 (5.6) | 3.8–6.9 |
| Amoxicillin–clavulanic acid tablet | 85 (8.7) | 72 (14.7) | 5 (2.7) | 162 (9.8) | 7.4–11.2 |
| Amoxicillin capsule | 39 (4.0) | 101 (20.6) | 11 (5.9) | 151 (9.1) | 8.1–9.9 |
| Crystalline penicillin injection | 21 (2.2) | 0 (0.0) | 1 (0.5) | 22 (1.3) | 1.1–1.8 |
| Cloxacillin injection/capsule | 12 (1.2) | 0 (0.0) | 2 (1.1) | 14 (0.8) | 0.2–1.1 |
| Ceftriaxone injection | 255 (26.2) | 79 (16.1) | 71 (37.8) | 405 (24.5) | 22.7–26.3 |
| Cephalexin capsule | 84 (8.6) | 2 (0.4) | 9 (4.8) | 95 (5.7) | 4.5–6.6 |
| Ceftazidime injection | 14 (1.4) | 2 (0.4) | 0 (0.0) | 16 (1.0) | 0.6–1.2 |
| Ciprofloxacin injection | 8 (0.8) | 0 (0.0) | 0 (0.0) | 8 (0.5) | 0.1–0.9 |
| Cefepime injection | 65 (6.7) | 25 (5.1) | 0 (0.0) | 90 (5.4) | 4.1–6.3 |
| Vancomycin injection | 202 (20.7) | 17 (3.5) | 0 (0.0) | 219 (13.2) | 12.1–14.3 |
| Gentamycin injection | 6 (0.6) | 0 (0.0) | 2 (1.1) | 8 (0.5) | 0.1–0.9 |
| Metronidazole injection | 126 (12.9) | 31 (6.3) | 0 (0.0) | 157 (9.5) | 8.3–10.1 |
| Azithromycin capsule | 52 (5.3) | 162 (33) | 0 (0.0) | 214 (12.9) | 11.6–13.8 |
| Total | 974 (58.9) | 491 (29.7) | 188 (11.4) | 1653 (100) | |
| Combination | |||||
| Metronidazole + ciprofloxacin | 5 (1.7) | 0 (0.0) | 0 (0.0) | 5 (1.2) | 0.9–1.6 |
| Azithromycin + ceftriaxone | 32 (11.0) | 81 (63.3) | 0 (0.0) | 113 (26.8) | 24.1–27.9 |
| Ceftriaxone + vancomycin | 130 (44.7) | 2 (1.6) | 0 (0.0) | 132 (31.4) | 28.3–32.8 |
| Metronidazole + vancomycin | 55 (18.9) | 15 (11.7) | 0 (0.0) | 70 (16.6) | 15.1–17.3 |
| Ciprofloxacin + vancomycin | 3 (1.0) | 0 (0.0) | 0 (0.0) | 3 (0.7) | 0.2–0.9 |
| Ceftazidime + vancomycin | 14 (4.8) | 2 (1.6) | 0 (0.0) | 16 (3.8) | 2.2–4.3 |
| Ceftriaxone + gentamycin | 1 (0.3) | 0 (0.0) | 1 (0.5) | 2 (0.5) | 0.1–0.9 |
| Ampicillin + gentamycin | 5 (1.7) | 0 (0.0) | 1 (0.5) | 6 (1.4) | 1.1–1.9 |
| Ceftriaxone + metronidazole | 26 (8.9) | 16 (12.5) | 0 (0.0) | 42 (10.0) | 8.8–11.7 |
| Azithromycin + amoxicillin–clavulanic acid | 20 (6.9) | 12 (9.4) | 0 (0.0) | 32 (7.6) | 6.1–8.3 |
Abbreviations: AKU-CSH, Aksum University College of Health Sciences and Comprehensive Specialized Hospital; Gyn/Obs, gynecology/obstetrics.